US 9403814
Crystalline forms of dihydropyrimidine derivatives
granted A61PA61P1/16A61P31/12
Quick answer
US patent 9403814 (Crystalline forms of dihydropyrimidine derivatives) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE LAKE PHARMA CO., LTD.
- Grant date
- Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61P, A61P1/16, A61P31/12, A61P31/20, A61P35/00